AKT1 and neoplasm: In mammals, the phosphoinositide-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is emerging as a critical integrator of intracellular signals, and important for apoptosis, malignant transformation, tumor progression, metastasis and radioresistance68–71.